1201784-90-8 Usage
Uses
Used in Medicinal Chemistry and Pharmaceutical Research:
6-Bromopyrrolo[2,1-f][1,2,4]triazine-2,4-diol is utilized as a key intermediate in the synthesis of novel pharmaceutical agents and drug candidates. Its unique structure and potential biological activities make it a valuable compound for the development of new therapeutic agents with improved efficacy and selectivity.
Used in Organic Synthesis:
6-Bromopyrrolo[2,1-f][1,2,4]triazine-2,4-diol serves as a versatile building block in the synthesis of other organic compounds, including complex organic molecules and bioactive molecules. Its presence in various synthetic pathways allows for the creation of a wide range of chemical entities with diverse applications.
Used in Material Development:
6-Bromopyrrolo[2,1-f][1,2,4]triazine-2,4-diol may be employed in the development of new materials with specific properties, such as high thermal stability, chemical resistance, or unique electronic properties. Its incorporation into material formulations can lead to the creation of advanced materials for various applications.
Used in Agricultural Chemistry:
6-Bromopyrrolo[2,1-f][1,2,4]triazine-2,4-diol may have potential applications in the field of agricultural chemistry, where it could be used as a component in the development of new agrochemicals, such as pesticides, herbicides, or plant growth regulators. Its unique structure and properties could contribute to the design of more effective and environmentally friendly agricultural products.
Check Digit Verification of cas no
The CAS Registry Mumber 1201784-90-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,1,7,8 and 4 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1201784-90:
(9*1)+(8*2)+(7*0)+(6*1)+(5*7)+(4*8)+(3*4)+(2*9)+(1*0)=128
128 % 10 = 8
So 1201784-90-8 is a valid CAS Registry Number.
1201784-90-8Relevant academic research and scientific papers
CDK kinase inhibitors
-
, (2020/12/30)
The invention discloses a compound with the general formula (I) and a salt thereof, wherein the compound can be taken as inhibitors of CDK kinase, particularly CDK4/6 kinase, and all variables are defined in the invention. The compound can be used for treating or preventing diseases such as cancer. The present application also relates to pharmaceutical compositions comprising the compound of formula (I).
Dipeptidyl peptidase - IV inhibitor, use thereof and intermediate and intermediate preparation method
-
Paragraph 0086; 0093-0094, (2018/07/30)
The invention discloses a compound shown as the general formula I or an optical isomer or a pharmaceutically acceptable salt thereof, an application thereof, an intermediate body thereof and a preparation method of the intermediate body thereof. In the formula I, R1, R2, R3, R4, R5 and R6 are defined in the specification. The compounds according to the formula I have the strong inhibition activity and the good selectivity and safety to dipeptidyl peptidase-IV. Thus, the compounds can be used for preparing medicines for treating and preventing dipeptidyl peptidase-IV related diseases.
TGF BETA RECEPTOR ANTAGONISTS
-
Page/Page column 151; 152; 153, (2017/03/08)
The invention relates generally to compounds that modulate the activity of TGFβR-1 and TGFβ R-2, pharmaceutical compositions containing said compounds and methods of treating proliferative disorders and disorders of dysregulated apoptosis, such as cancer, utilizing the compounds of the invention.
